Latest News about BIIB
Recent news which mentions BIIB
7 Cheap Blue-Chip Stocks to Buy Before They Rebound
August 05, 2022
From InvestorPlace
From MarketWatch
Tickers
BIIB
From Motley Fool
Bill Gates, Jeff Bezos Unite To 'Change The Course' Of Neurological Disorder Impacting 6.5 Million Americans
July 30, 2022
From Benzinga
A Monoclonal Antibody Treatment For ALS Could Begin Human Trials By 2023, According To Pasithea
July 28, 2022
From Benzinga
From InvestorPlace
From Benzinga
FDA Accepts Biogen's Submission For Neurodegenerative Disease Drug Under Priority Review
July 26, 2022
From Benzinga
From Benzinga
From Benzinga
With All Eyes On Lecanemab Read Out In Alzheimer's, Uncertainty Overshadows Biogen's Q2 Beat
July 21, 2022
Tickers
BIIB
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Biogen Reveals $900M Settlement In Whistleblower's MS Drug Kickbacks Lawsuit Days Before Trial
July 21, 2022
From Benzinga
Stranger Things Do Happen As Netflix Surprises Investors
July 20, 2022
From Benzinga
From Benzinga
From Benzinga
Earnings Beat, Increased FY22 Outlook, Rising Biosimilar Competition: Biogen's Q2 Highlights
July 20, 2022
Tickers
BIIB
From Benzinga
Short-term pain for long-term gains. Investors need to settle in for the long haul, says Bernstein.
July 20, 2022
From MarketWatch
Earnings Scheduled For July 20, 2022
July 20, 2022
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.